GRIFOLS | GRF - Operating Expenses

Stock Price
8.95
Daily Change
0 0%
Monthly
-0.11%
Yearly
5.12%
Q2 Forecast
9.40

GRIFOLS reported EUR1.71B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alcon AG USD 2.41B 123M Dec/2025
Almirall EUR 517.4M 32K Dec/2025
Amadeus IT EUR 1.28B 129M Dec/2025
Amarin USD 51.48M 113K Dec/2025
argenx SE USD 914.57M 137.58M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Cie Automotive EUR 1.69B 20.74M Dec/2025
Demant DKK 9.63B 241M Dec/2025
Ence Energia y Celulosa EUR 224.43M 29.03M Dec/2025
Essilor EUR 13.09B 1.07B Dec/2025
Ferrovial EUR 4.62B 584M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
Genmab DKK 798M 235M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Inditex EUR 9.64B 2.2B Dec/2025
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
Smith & Nephew USD 2.52B 84M Dec/2025
UCB EUR 2.96B 196M Dec/2025
Viscofan EUR 262.6M 2.21M Mar/2026